不同17DD黄热病疫苗在金头狮狨(Leontopithecus chrysomelas)中的安全性与免疫原性:同源减毒活疫苗接种后抑制病毒血症与RNA血症
研究将易感金头狮狨分别接种商业巴西17DD黄热病减毒活疫苗、β-丙内酯灭活全病毒疫苗或植物源重组亚单位疫苗,评估安全性、免疫原性及攻毒后病毒血症与RNA血症阻断。减毒活疫苗三个浓度均诱导中和抗体,16只中仅1只攻毒后可检出病毒血症和RNA血症,阻断效果超过90%。
要点
- 17DD减毒活疫苗在16只金头狮狨中仅1只攻毒后可检出病毒血症和RNA血症,阻断效果超过90%。
- 灭活疫苗三剂方案在6只中5只诱导中和抗体并阻止攻毒后病毒血症和RNA血症,阻断83%。
- 植物源疫苗两剂方案在6只中5只诱导中和抗体、3只阻止病毒血症和RNA血症,阻断50%。
核心结论
- 研究可支持在新世界灵长类中使用减毒或非复制型黄热病疫苗,以应对巴西近期疾病暴发。
研究设计与样本
- 易感金头狮狨分别接种商业巴西17DD黄热病减毒活疫苗、纯化全病毒β-丙内酯灭活疫苗或植物源重组亚单位疫苗,评估安全性、免疫原性及攻毒后病毒血症和RNA血症阻断。
主要发现
- 接种减毒活疫苗或以其同源攻毒的动物均未观察到黄热病临床表现。
- 减毒活疫苗三个浓度均诱导中和抗体,16只中仅1只攻毒后可检出病毒血症和RNA血症,阻断效果超过90%。
- 灭活疫苗在6只中5只诱导中和抗体并阻止攻毒后病毒血症和RNA血症,三剂方案阻断83%。
- 植物源疫苗在6只中5只诱导中和抗体,两剂方案在6只中3只阻止病毒血症和RNA血症,阻断50%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Yellow fever (YF) is a viral disease that affects both humans and non-human primates (NHPs). Neotropical monkeys are more severely stricken by YF and the impact of the disease can be devastating to the endangered golden-headed lion tamarins (GHLTs, Leontopithecus chrysomelas). Susceptible GHLTs were immunized with the commercial Brazilian YF 17DD live attenuated vaccine or two other experimental non-replicating YF vaccines: a purified whole-virus, b-propiolactone-inactivated vaccine and a plant-derived recombinant subunit vaccine. Safety, immunogenicity and viremia and RNAemia blockade were characterized. No YF clinical manifestations were observed in any of the GHLTs that received the attenuated virus, either as a vaccine or as the homologous vaccination with the live attenuated vaccine used as the challenge virus. All three concentrations of the attenuated vaccine induced neutralizing antibodies and only one in 16 animals had detectable viremia and RNAemia after challenge. The inactivated vaccine elicited neutralizing antibodies preventing post-challenge viremia and RNAemia in five out of six animals. The plant-based vaccine induced neutralizing antibodies in five out of six animals and prevented viremia and RNAemia in three out of six against challenge. The safety profile and the immunogenicity of the YF attenuated vaccine were demonstrated in GHLTs with a blocking effectiveness over 90 %, where blockade can be defined as the capacity to prevent viremia and RNAemia after homologous vaccination with the live attenuated vaccine. The use of the inactivated vaccine in this species served as a preliminary pre-clinical study for this approach and after administration in three-dose regimen demonstrated a blocking profile of 83 %. Using a two-dose regimen, the plant-based vaccine was able to block viremia and RNAemia in 50 % of the animals. The present study can endorse the use of attenuated or non-replicating yellow fever vaccines in New World primates threatened by the recent disease outbreaks in Brazil.
引用
- Silva-Fernandes AT, Moreira SB, Gaspar LP, et al. Safety and immunogenicity of different 17DD yellow fever vaccines in golden-headed tamarins (Leontopithecus chrysomelas): Inhibition of viremia and RNAemia after homologous live-attenuated vaccination. Vaccine. 2025. PMID: 39826431. doi:10.1016/j.vaccine.2025.126721
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。